Departed
Carrie Schwarz
director
KAYS ·
Kaya Holdings, Inc.
Effective April 24, 2025, Carrie Schwarz stepped down as a director of the Company.
Ready 8-Ks
21
Latest filing
November 28, 2025, 6:59 PM ET
Top materiality
0.90
Event mix
other_material ×17 · leadership ×2 · regulatory ×1
Sentiment
7 pos · 1 neg · 13 neu
Executive change
recent →
Recent 8-K filings for KAYS
Highest-materiality recent filing
Kaya Holdings restructures preferred stock and debt; insiders gain 40% voting power
- Director Jordi Arimany resigned Sept. 8, 2021; Mitchell Chupak appointed, receiving 100k shares annually.
- CEO Frank and BMN exchanged Series C Preferred (28.89 common per share, 16.4% combined voting) for Series D Preferred giving 40% voting power on as-converted basis.
-
Kaya Holdings appoints Richard D. Seay to board of directors effective Nov 25, 2025
Richard D. Seay, 72, appointed to Kaya Holdings board effective Nov 25, 2025.
-
Kaya Holdings converts $13.98M debt to equity; CVC gains 56.19% voting control
Issued 642,868,838 shares to satisfy $13,979,148 of debt, converting over 90% of existing debt into equity.
-
Kaya Holdings engages advisors for cryptocurrency subsidiary and digital asset treasury strategy
Engaged Greentree Financial Group and Conduit Advisors to develop a new crypto operating subsidiary.
-
Kaya Holdings Director Carrie Schwarz Steps Down Effective April 24, 2025
Carrie Schwarz stepped down as a director of Kaya Holdings, Inc. effective April 24, 2025.
-
Kaya Holdings' psilocybin treatment center covered by Portland TV station KATU
Company launched The Sacred Mushroom psilocybin treatment center in Portland, Oregon.
-
Kaya Holdings increases authorized common shares from 500M to 1.5B
Authorized shares increased to 1.5 billion from 500 million.
-
CEO Craig Frank will be the first guest to receive psilocybin treatment at the center.
-
Majority-owned subsidiary Fifth Dimension Therapeutics begins accepting appointments at The Sacred Mushroom in Portland, Oregon.
-
Kaya Holdings awarded Oregon psilocybin service center license; first guests within 30 days
Oregon Health Authority licenses KAYS to operate The Sacred Mushroom psilocybin treatment center in Portland.
-
Kaya Holdings CEO discusses upcoming psilocybin treatment center in podcast
CEO Craig Frank and consultant Dave Jones feature on Investor Ideas Potcast about The Sacred Mushroom center.
-
Kaya Holdings unveils The Sacred Mushroom psilocybin center in Portland, Oregon
KAYS unveils The Sacred Mushroom, an 11,000 sq ft psilocybin center in Portland, Oregon.
-
KAYS closes additional $600K non-dilutive bridge financing for Oregon psilocybin center
Total bridge financing since June 2023 is $600K: $100K short-term due Mar 15, 2023, $500K repayable from 10% of quarterly revenues, balance due Jun 30, 2025.
-
Leased premium space on top floor of Falcon Building in Portland, OR for planned psilocybin treatment center.
-
Kaya Holdings issues shareholder update by email on May 12, 2023
Company distributed a shareholder communications update via email on May 12, 2023.
-
Kaya Holdings sells Oregon property and retail cannabis store for ~$500k net proceeds
Sold Lebanon, OR property for $769,500; net proceeds ~$302k after repaying loans and advances.
-
Fifth Dimension Therapeutics reaches agreement in principle with Total Holistic Center to develop ketamine treatment protocols.
-
Kaya Holdings launches Fifth Dimension Therapeutics to enter psychedelic treatment market
Fifth Dimension Therapeutics will target PTSD, addiction, eating disorders, and treatment-resistant mental health conditions.
-
Greek Kaya project received Cannabis Installation License for 50K sq ft medical cannabis facility in Epidaurus, Greece.
-
Kaya Holdings restructures preferred stock and debt; insiders gain 40% voting power
Director Jordi Arimany resigned Sept. 8, 2021; Mitchell Chupak appointed, receiving 100k shares annually.
-
Kaya Holdings sells Oregon cannabis facility for $1.325M, cancels 1M shares
Sale of Eugene, OR facility for $1.325M gross proceeds; funds cleared escrow.
-
Bruce Burwick surrendered 1,006,671 shares (6.4% of float) to KAYS for cancellation as part of settlement.
Executive changes
Departed
Jordi Arimany
director
KAYS ·
Kaya Holdings, Inc.
On December 26, 2021 our board of directors accepted the resignation of Jordi Arimany as a director of the Company effective as of September 8, 2021.
Appointed
Mitchell Chupak
director
KAYS ·
Kaya Holdings, Inc.
On December 26, 2021, our board of directors appointed Mitchell Chupak to fill the vacancy created by the resignation of Jordi Arimany.
Materiality & sentiment trend
Max materiality 0.90 · Median 0.55 · Most common event other_material